Previous 10 | Next 10 |
The following slide deck was published by Compugen Ltd. in conjunction with this Read more ...
Image source: The Motley Fool. Compugen Ltd. (NASDAQ: CGEN) Q1 2020 Earnings Call May 6, 2020 , 8:30 a.m. ET Operator Continue reading
Compugen Ltd. (CGEN) Q1 2020 Earnings Conference Call May 6, 2020 8:30 a.m. ET Company Participants Elana Holzman - Director of IR and Corporate Communications Anat Cohen-Dayag - President and CEO Henry Adewoye - Chief Medical Officer Ari Krashin - CFO and COO Conference Cal...
HOLON, Israel , May 6, 2020 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the first quarter ended March 31, 2020 . "We have entered 2020 well pos...
Over the past decade, many immunotherapies have been investigated for the treatment of cancer, with limited success. Will Compugen (NASDAQ: CGEN) become yet another casualty in an endless uphill battle? Compugen claims a key competitive advantage: proprietary algorithms it can use to detect...
HOLON, Israel , April 27, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, will present updated results from its ongoing Phase 1 dose escalation study of COM701, a first-in-class a...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
HOLON, Israel , April 23, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its first quarter 2020 financial results on Wednesday...
SAExploration Holdings (NASDAQ: SAEX ) +177% on $27M new project in Greece. More news on: SAExploration Holdings, Inc., B.O.S. Better Online Solutions Ltd., The Peck Company Holdings, Inc., Stocks on the move, Read more ...
The European Patent Office (EPO) has granted Compugen (NASDAQ: CGEN ) a new patent for the composition of COM701 or backup antibodies for the treatment of cancer. More news on: Compugen Ltd., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors PR Newswire FDA clearance triggers a $30 million milestone payment from Gilead Company on track to initiate a Phase 1 trial for COM503, a differentiated antibody approach to harne...
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 PR Newswire HOLON, Israel , July 23, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target ...
Compugen to Present at Upcoming Antibody Industrial Symposium PR Newswire HOLON, Israel , June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, t...